Literature DB >> 7212972

Delusional depression. A distinct clinical entity?

A H Glassman, S P Roose.   

Abstract

The prognostic importance of delusions in the depressive syndrome had been a major focus of study before somatic therapies were available. Recently, the growing evidence that delusional depressives respond at a significantly lower rate to tricyclic antidepressants than do nondelusional depressives has revived this interest. That evidence is reviewed, and the demographic data and pretreatment clinical phenomenology of a series of hospitalized depressed patients were analyzed to see if differences existed between the delusional and nondelusional groups. Delusional unipolar depressives were less likely to recover while receiving placebo, had significantly more psychomotor retardation, and showed a trend toward fewer previous episodes than nondelusional unipolar depressives.

Entities:  

Mesh:

Year:  1981        PMID: 7212972     DOI: 10.1001/archpsyc.1981.01780290058006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  16 in total

Review 1.  Psychotic major depression: a benefit-risk assessment of treatment options.

Authors:  Audrey R Tyrka; Lawrence H Price; Marcelo F Mello; Andrea F Mello; Linda L Carpenter
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Management of depression in general practice.

Authors:  S Brandon
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-01

3.  Antidepressant effects of electroconvulsive therapy: current or seizure?

Authors:  J F Deakin
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-02

4.  Measuring psychotic depression.

Authors:  S D Østergaard; B S Meyers; A J Flint; B H Mulsant; E M Whyte; C M Ulbricht; P Bech; A J Rothschild
Journal:  Acta Psychiatr Scand       Date:  2013-06-25       Impact factor: 6.392

Review 5.  Rating scales measuring the severity of psychotic depression.

Authors:  S D Østergaard; A J Rothschild; A J Flint; B H Mulsant; E M Whyte; A K Leadholm; P Bech; B S Meyers
Journal:  Acta Psychiatr Scand       Date:  2015-05-27       Impact factor: 6.392

Review 6.  A model of placebo response in antidepressant clinical trials.

Authors:  Bret R Rutherford; Steven P Roose
Journal:  Am J Psychiatry       Date:  2013-07       Impact factor: 18.112

7.  A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).

Authors:  Barnett S Meyers; Alastair J Flint; Anthony J Rothschild; Benoit H Mulsant; Ellen M Whyte; Catherine Peasley-Miklus; Eros Papademetriou; Andrew C Leon; Moonseong Heo
Journal:  Arch Gen Psychiatry       Date:  2009-08

8.  Stability of psychotic symptomatology (delusions, hallucinations), affective syndromes, and schizophrenic symptoms (thought disorder, incongruent affect) over episodes in remitting psychoses.

Authors:  G Winokur; C Scharfetter; J Angst
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 9.  Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.

Authors:  Julia M Sheffield; Nicole R Karcher; Deanna M Barch
Journal:  Neuropsychol Rev       Date:  2018-10-20       Impact factor: 7.444

Review 10.  Current issues in the classification of psychotic major depression.

Authors:  Jennifer Keller; Alan F Schatzberg; Mario Maj
Journal:  Schizophr Bull       Date:  2007-06-04       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.